Publications

1. Doravirine (Pifeltro®) for the treatment of adults infected with HIV-1

   The National Health Care Institute has completed its assessment whether Pifeltro® (doravirine) can be included in the Medication ...

   Report | 27-06-2019

2. Erenumab (Aimovig®) for the prophylaxis of adults with migraine

   The National Health Care Institute has completed its assessment whether erenumab (Aimovig®) for the prophylaxis of adults with ...

   Report | 27-06-2019

3. Ipilimumab/nivolumab (Yervoy®/Opdivo®) for the first-line treatment of adult patients with intermediate/poor-risk advanced renal cell carcinoma

   The National Health Care Institute has completed its assessment whether ipilimumab/nivolumab (Yervoy®/Opdivo®) for the first-line ...

   Report | 29-05-2019

4. Venetoclax (Venclyxto®) in combination with rituximab for the treatment of chronic lymphocytic leukaemia (CLL)

   Zorginstituut Nederland has completed its assessment whether venetoclax (Venclyxto®) in combination with rituximab for the ...

   Report | 08-05-2019

5. Lumacaftor/ivacaftor (Orkambi®) for the treatment of cystic fibrosis

   The National Health Care Institute carried out a marginal assessment in relation to extending the specific conditions for the ...

   Report | 30-04-2019

6. Tezacaftor/ivacaftor (Symkevi®) with ivacaftor monopreparation (Kalydeco®) for the treatment of cystic fibrosis

   The National Health Care Institute carried out an assessment in relation to extending the specific conditions for the medicinal ...

   Report | 24-04-2019

7. Assessment of 'established medical science and medical practice’ - a technical modification

   This report is a supplement to the existing Dutch assessment framework dating form 2015. It can be used to investigate whether an ...

   Report | 23-04-2019

8. Brexpiprazole (Rxulti®) for the treatment of schizophrenia in adults

   The National Health Care Institute carried out a marginal assessment whether the product brexpiprazole (Rxulti®) can be accepted ...

   Report | 16-04-2019

9. Pitolisant (Wakix®) for the treatment of narcolepsy in adults

   The National Health Care Institute  carried out a marginal assessment whether pitolisant (Wakix®) is interchangeable with a drug ...

   Report | 15-04-2019

10. Glycopyrronium bromide (Sialanar®) for the symptomatic treatment of severe sialorrhoea

    The National Health Care Institute carried out an assessment whether the product glycopyrronium bromide (Sialanar®) is ...

    Report | 09-04-2019